<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52127">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02130830</url>
  </required_header>
  <id_info>
    <org_study_id>14-038</org_study_id>
    <nct_id>NCT02130830</nct_id>
  </id_info>
  <brief_title>Topical Anesthesia Versus Placebo to Decrease Pain in Rubber Band Ligation for Treatment of Internal Hemorrhoids</brief_title>
  <official_title>Topical Anesthesia Versus Placebo to Decrease Post Procedure Pain in Rubber Band Ligation for the Treatment of Grade I - III Symptomatic Internal Hemorrhoids. A Single Institution, Double Blinded, Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <authority>Chile: Instituto de Salud Pública de Chile</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rubber band ligation is a simple and effective procedure for the management of hemorrhoidal
      disease. However, 90% of patients have some degree of discomfort associated with the
      procedure and up to 40% develop clinically significant pain. Some studies have used local
      anesthesia to reduce pain with promising results, but the use of topical anesthesia has not
      been reported before.

      The investigators hypothesize that the use of topical anesthesia before rubber band ligation
      significantly reduces post procedure pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain measured in analog visual scale</measure>
    <time_frame>up to 72 hours post procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure morbidity</measure>
    <time_frame>up to 30 days post procedure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain measured in visual analog scale in subgroups</measure>
    <time_frame>up to 72 hours</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hemorrhoids</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Topical anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of topical 2,5% lidocaine + 2,5% prilocaine gel to the anal canal before the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Application of placebo gel into the anal canal before the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical 2,5% lidocaine + 2,5% prilocaine gel</intervention_name>
    <description>The topical gel is administered in the anal canal at the moment of the anoscopy</description>
    <arm_group_label>Topical anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo gel to mimic topical anesthesia administered in the anal canal at the moment of the anoscopy</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic grade I - III hemorrhoidal disease

        Exclusion Criteria:

          -  Chronic liver disease

          -  Use of class 3 antiarrythmics

          -  Coagulopathy

          -  Grade IV hemorrhoidal disease

          -  Inflammatory bowel disease

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gellona Jose, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bellolio Felipe, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Gellona, MD</last_name>
    <phone>+56996784801</phone>
    <email>jgellona@uc.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gonzalo Palominos, MD</last_name>
    <phone>+56223546882</phone>
    <email>gapalominos@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clínico Universidad Católica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gellona Jose, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemorrhoids</keyword>
  <keyword>Rubber band ligation</keyword>
  <keyword>pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
